Pictet Asset Management (Switzerland)’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
$78M Sell
3,696,315
-234,448
-6% -$4.45M 0.09% 227
2023
Q1
$67M Sell
3,930,763
-55,786
-1% -$1.08M 0.08% 246
2022
Q4
$79.7M Buy
3,986,549
+568,784
+17% +$11M 0.12% 212
2022
Q3
$73.6M Sell
3,417,765
-380,176
-10% -$9.12M 0.11% 223
2022
Q2
$74.9M Buy
3,797,941
+242,092
+7% +$5.07M 0.1% 230
2022
Q1
$83.6M Buy
3,555,849
+657,094
+23% +$15.3M 0.09% 241
2021
Q4
$79M Sell
2,898,755
-10,445
-0.4% -$299K 0.08% 265
2021
Q3
$80.1M Buy
+2,909,200
New +$76.3M 0.09% 261

Other funds holding INSM

Pictet Asset Management (Switzerland)'s INSM Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) reduced its Insmed (INSM) stake by 6% in Q2 2023, selling an estimated $4.45M and leaving 3,696,315 shares worth $78M. The position accounts for 0.09% of the portfolio, ranked #227.

Pictet Asset Management (Switzerland) first reported a position in INSM in Q3 2021 and has held it in 8 quarters since. The position peaked at $83.6M in Q1 2022. 223 funds tracked by Wall St. Rank hold INSM as of Q2 2023.

  • Pictet Asset Management (Switzerland) held 3,696,315 shares of Insmed worth $78M as of Q2 2023.
  • Pictet Asset Management (Switzerland) sold 234,448 Insmed shares in Q2 2023, an estimated $4.45M.
  • Insmed made up 0.09% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #227 holding.
  • Pictet Asset Management (Switzerland) first reported a position in Insmed in Q3 2021 and has held it in 8 quarters since.
  • Pictet Asset Management (Switzerland)'s Insmed position peaked at $83.6M in Q1 2022.
  • 223 funds tracked by Wall St. Rank held Insmed as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.